Nerve blocks may cut opioid use in newborn cleft lip repair
NCT ID NCT06067854
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This completed study looked at 111 newborns who had cleft lip repair surgery. Researchers compared those who received a regional nerve block for pain relief to those who did not. The goal was to see if the nerve block reduced the amount of opioid pain medicine needed during and after surgery. The study also checked for complications and how soon babies could eat after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If the nerve block reduces opioid use, it could point to safer pain management for newborns after cleft lip repair.
- What could go wrong
- This is a small, retrospective study, so it can't prove cause and effect. Results may not apply to all newborns or other surgeries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
111 people
The number who actually took part.
- Started
-
Jan 2018
- Finished
-
Jan 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Neonates with cleft lips who underwent primary cleft lip repair surgery in tertiary center paediatric anesthesiology department
- Ages
-
0 to 28 days
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * neonates with unilateral or bilateral cleft lip (U/BCL), all neonates with unilateral or bilateral cleft lip and alveolus (U/BCLA) or with unilateral or bilateral cleft lip, alveolus and palate (total cleft; U/BCLAP) who underwent cleft lip repair surgery in the neonatal period * the study period (1/2018-12/2021) Exclusion Criteria: * ● presence of coagulopathy * thrombocytopenia or thrombopathy * patients at risk of malignant hyperthermia * patients who were not neonates (older than 28 days) * patients who required postoperative mechanical ventilation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cleft lip are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brno University Hospital
Brno, South Moravian, 62500, Czechia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom-Shaped nose splint may ease recovery for kids after cleft lip surgery
- Can we predict breathing problems in cleft surgery? new study aims to find out
- MRI scans reveal hidden causes of speech issues in cleft palate kids
- New surgical trick may improve nose shape after cleft lip repair
- Could skipping opioids make Kids' cleft surgery safer?
- New jaw expander could improve smiles for kids with cleft lip and palate